Kala Pharmaceuticals Receives $11,500,000 Series A Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f168c133-51e1-4cdf-bdda-97e4819d06ad&Preview=1 -
Date
3/1/2013 -
Company Name
Kala Pharmaceuticals -
Mailing Address
135 Beaver St. Waltham, MA 02452 -
Company Description
Kala Pharmaceuticals, Inc. is a biotechnology company founded upon a proprietary drug delivery technology. By utilizing this unique technology, Kala aims to address unmet therapeutic needs of various diseases and conditions in a fundamentally novel way. -
Website
http://www.kalarx.com -
Transaction Type
Venture Equity -
Transaction Amount
$11,500,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds from the financing will be used to advance a portfolio of innovative ophthalmic programs based on Kala’s Mucosal Penetrating Product (MPP) platform through clinical proof of concept. -
M&A Terms
-
Venture Investor
Crown Venture Fund -
Venture Investor
Lux Capital -
Venture Investor
Polaris Partners -
Venture Investor
Third Rock Ventures
